SIGGF (Sigma Healthcare) EBITDA: $423 Mil (TTM As of Dec. 2025)


SIGGF Sigma Healthcare Ltd SIGGF
59 GF Score
Price $2.35
GF Value $0.31
! 8 Warning Signs
View Full Analysis

What is Sigma Healthcare EBITDA?

Sigma Healthcare SIGGF 59 EBITDA is $423 Mil as of Dec. 2025. GuruFocus rates SIGGF with a GF Score™ of 59/100 and a GF Value™ of $0.31. The stock has 8 warning signs investors should review.

Sigma Healthcare's EBITDA for the six months ended in Dec. 2025 was $403 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $423 Mil.

During the past 12 months, the average EBITDA Growth Rate of Sigma Healthcare was 1382.10% per year. During the past 3 years, the average EBITDA Growth Rate was 22.40% per year. During the past 5 years, the average EBITDA Growth Rate was 8.30% per year. During the past 10 years, the average EBITDA Growth Rate was -7.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Sigma Healthcare was 119.90% per year. The lowest was -35.00% per year. And the median was 4.40% per year.

Sigma Healthcare's EBITDA per Share for the six months ended in Dec. 2025 was $0.04. Its EBITDA per share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.05.

During the past 12 months, the average EBITDA per Share Growth Rate of Sigma Healthcare was 114.70% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 5.30% per year. During the past 5 years, the average EBITDA per Share Growth Rate was 1.40% per year. During the past 10 years, the average EBITDA per Share Growth Rate was -8.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Sigma Healthcare was 63.60% per year. The lowest was -35.10% per year. And the median was 5.30% per year.

Sigma Healthcare  (OTCPK:SIGGF) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Sigma Healthcare EBITDA Related Terms


Sigma Healthcare EBITDA Historical Data

* Premium members only.

The historical data trend for Sigma Healthcare's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sigma Healthcare EBITDA Chart

Sigma Healthcare Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 73.08 21.70 34.91 35.34 34.56

Sigma Healthcare Semi-Annual Data
Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Dec25
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.86 12.84 15.84 19.77 403.38

SIGGF vs MCK, COR, CAH: EBITDA Comparison

For the Medical Distribution subindustry, Sigma Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sigma Healthcare EV-to-EBITDA vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sigma Healthcare's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sigma Healthcare's EV-to-EBITDA falls into.


SIGGF
59GF Score
Sigma Healthcare Ltd SIGGF
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Sigma Healthcare's EBITDA for the fiscal year that ended in Jan. 2025 is calculated as

Sigma Healthcare's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Jan. 2025, Sigma Healthcare's EBITDA was $35 Mil.

Sigma Healthcare's EBITDA for the quarter that ended in Dec. 2025 is calculated as

Sigma Healthcare's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Dec. 2025, Sigma Healthcare's EBITDA was $403 Mil.

EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $423 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of $423 Mil mean?
Sigma Healthcare (SIGGF) has a EBITDA of $423 Mil as of Dec. 2025. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Sigma Healthcare.
Is Sigma Healthcare's EBITDA too high?
Sigma Healthcare's current EBITDA is $423 Mil. Overall, Sigma Healthcare has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Sigma Healthcare's EBITDA compare to MCK and COR?
Sigma Healthcare's EBITDA of $423 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for a Medical Distribution company?
A good EBITDA depends on the Medical Distribution industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Sigma Healthcare. Sigma Healthcare's current EBITDA is $423 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigma Healthcare stock overvalued right now?
Sigma Healthcare (SIGGF) has a current EBITDA of $423 Mil. The stock's GF Value™ is $0.31, compared to a current price of $2.35 — trading 657.4% above its estimated fair value. The current EBITDA is $423 Mil. Sigma Healthcare's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For Sigma Healthcare (SIGGF), the current EBITDA is $423 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sigma Healthcare (SIGGF) Overvalued in 2026?

Based on GuruFocus' analysis, Sigma Healthcare stock appears to be overvalued. The current stock price of $2.35 is trading 657.4% above its estimated GF Value™ of $0.31.

Key valuation signals for SIGGF:

  • EBITDA: $423 Mil
  • GF Value™: $0.31 vs. price of $2.35 (657.4% above fair value)
  • GF Score™: 59/100 with 8 warning signs

No single metric tells the full story. See the SIGGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sigma Healthcare Business Description

Other Exchanges SIG:Australia
Address 6 Albert Street, Preston, VIC, AUS, 3072
Sigma Healthcare is Australia's largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025. Sigma is also Australia's largest full-line wholesaler to franchised and independent pharmacies and distributes a broad range of pharmacy products, including prescription medicines, over-the-counter products, and front of store, or FOS, products, at low prices. The group also operates in New Zealand, Ireland, China, and Dubai, has a growing private label range, and offers third-party logistics services.
59GF Score

Get the complete analysis for SIGGF

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.35
Price
$0.31
GF Value